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1 
 Abstract  
 
Digital technologies such as smartphones are transforming the way scientists conduct           
biomedical research using real-world data. Several remotely-conducted studies have         
recruited thousands of participants over a span of a few months. Unfortunately, these             
studies are hampered by substantial participant attrition, calling into question the           
representativeness of the collected data including generalizability of findings from these           
studies. We report the challenges in retention and recruitment in eight remote digital             
health studies comprising over 100,000 participants who participated for more than           
850,000 days, completing close to 3.5 million remote health evaluations. Survival           
modeling surfaced several factors significantly associated(P < 1e-16) with increase in           
median retention time ​i) Clinician referral(increase of 40 days), ​ii) Effect of            
compensation (22 days), ​iii) ​Clinical conditions of interest to the study (7 days) and ​iv)               
Older adults(4 days). Additionally, four distinct patterns of daily app usage behavior that             
were also associated(P < 1e-10) with participant demographics were identified. Most           
studies were not able to recruit a representative sample, either demographically or            
regionally. Combined together these findings can help inform recruitment and retention           
strategies to enable equitable participation of populations in future digital health           
research. 
 
 
 
 
 
 
2 
 Introduction 
 
Traditional in-person clinical trials serve as the cornerstone of modern healthcare           
advancement. While a pivotal source of evidence generation for advancing clinical           
knowledge, in-person trials are also costly and time-consuming, typically running for 3-5            
years from conception to completion, at a cost of millions of dollars per study. These               
timelines have often meant that promising treatments take years to get to market, which              
can create unnecessary delays in advancing clinical practice. Additionally, clinical          
research suffers from several other challenges​1​,​2 including 1) recruiting sufficiently large           
and diverse cohorts quickly, and 2) tracking day-to-day fluctuations in disease severity            
that often go undetected in episodic in-clinic evaluations​3,4​. Scientists have recently           
turned to digital technology​5,6 to address these challenges, hoping to collect real-world            
evidence​7 from large and diverse populations to track long-term health outcomes and            
variations in disease trajectories at a fraction of the cost of traditional research​8​.  
 
The global penetration​9 and high-frequency usage of smartphones (up to 4 hours            
daily​10,11​) offer researchers a cost-effective means to recruit a large number of            
participants into health research across the US (and the world)​12,13​. In the last 5 years,               
researchers have conducted several large scale studies​14–22 including deploying         
interventions​23,24 and running clinical trials​25–27 using mobile technologies. These studies          
are able to recruit at-scale because participants can be identified and consented​28 to             
participate in the study without ever having stepped foot in a research lab, with              
significantly lower costs than conventional clinical trials​23,24​. Mobile technologies also          
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 allow investigators an opportunity to collect data in real-time based on people’s daily             
lived experiences of the disease, that is, real-world data​7​. Rather than retrospectively            
asking people to recall their health over the past week or month, researchers using              
mobile technologies can assess participants frequently including outside clinic and at           
important points in time without having to rely on recall that is known to have bias​29​.                
While these studies show the utility of mobile technology, challenges in participant            
diversity and long-term participant retention still remain a problem​30​. 
 
Digital studies continue to suffer from long-term participant retention problems that also            
plagued internet-based studies​31,32 in the early 2000s​33–35​. However, our understanding          
of factors impacting retention in remote research remains to be limited. High levels of              
user attrition combined with variations in long-term app usage may result in the creation              
of a cohort that may not represent the population of interest in regard to demographics,               
disease status, and disability. This has called into question the reliability and utility of              
the collected data from these studies​36​. Furthermore, while for many digital health            
studies, anyone eligible can self-select to join, this broad “open enrollment” recruitment            
model may be prone to selection and ascertainment bias​36​. Systematic evaluation of            
participant recruitment and retention could help detect such confounding characteristics          
that may be present in large scale remotely collected data and has been shown to               
severely impact the generalizability of the derived statistical inference​36,37​. Participant          
retention may also be partially dependent on the engagement strategies used in remote             
research. While most studies assume participants will remain in a study for altruistic             
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 reasons​38​, other studies provide compensation for participant time​39​, leverage         
partnerships with local community organizations, clinical registries, and clinicians to          
encourage participation​23​,​24​. Although monetary incentives are known to increase         
participation in research​40​, we know little about the relative impact of demographics,            
recruitment and different engagement strategies on participant retention, especially in          
remote health research.  
 
The purpose of this study is to document the drivers of retention, and long term study                
app usage in remote research. To investigate these questions we have compiled user             
engagement data from eight digital health studies that enrolled more than 100,000            
participants from throughout the US between 2014-2019. These studies assessed          
different disease areas including asthma, endometriosis, heart disease, depression,         
sleep health, neurological diseases and consisted of a combination of longitudinal           
subjective surveys and objective sensor-based tasks including passive data​41 collection.          
The diversity of the collected data allows for a broad investigation of different participant              
characteristics and engagement strategies that may be associated with higher retention           
including assessment of representational bias in the collected real-world data. 
 
Results 
Participant Characteristics  
  
The combined user activity data from eight digital health studies resulted in a pool of               
109,914 participants who together completed approximately 3.5 million tasks on more           
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 than 850,000 days (Table 1). Across the studies, the majority (Median=65.2%) of            
participants were between 17-40 years with those 60 years and older being the least              
represented (Median across studies=6% of the study population). The sample had a            
larger proportion of Females (Median=56.9%) however it varied significantly across the           
studies (Range=29.4-100%). A majority of recruited participants were Non-Hispanic         
Whites (Median=75.3%) followed by Hispanic/Latinos (Median=8.21%) and       
African-American/Blacks (Median=3.45%) (Table 2). With the exception of the Brighten          
study, the race/ethnic diversity of the sample also showed a marked difference from the              
2010 census data. Minority groups were under-represented in the present sample with            
Hispanic/Latinos and African-America/Black showing a substantial difference of -8.09%         
and -9.15% respectively compared to the 2010 census metrics (Table 2, Figure 1-b).             
Across the studies, the median proportion of recruited participants per state showed            
notable differences from the state’s population proportion of the US (Figure 1.a).  
 
Participant Retention  
 
As is the nature of these studies, participants were required to complete all health              
assessments and other study-related tasks (eg: treatments) through a mobile          
application (app) throughout the length of the study. The median time participants            
engaged in the study in the first 12 weeks was 5.5 days of which in-app tasks were                 
performed on 2 days (Table 2). Higher proportions of active tasks were completed by              
participants during the evening(4-8 PM) and night(8-12 Midnight) hours (Figure 2-a).           
Across the studies, the median retention time varied significantly (P <1e-16) between 2             
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 and 12 days with the Brighten study being an outlier with a higher median retention of                
26 days (Figure 2-b). A notable increase in median retention time was seen for              
sub-cohorts that continue to engage with the study apps after day one and beyond              
(Figure 2-c). For example, the median retention increased by 25 days for the sub-cohort              
that was engaged for the first 8 days. The participant retention also showed a significant               
association with participant characteristics. While older participants (60 years and          
above) were the smallest proportion of the sample, they remained in the study for a               
significantly longer duration (Median=7 days, P<1e-16) compared to the majority          
younger sample (17-49 years) (Figure 2-d). Participants declared gender showed no           
significant difference in retention (P = 0.3). People with clinical conditions of interest to              
the study (e.g.: heart disease, depression, multiple sclerosis) remained in the studies for             
a significantly longer time (Median=13 days, P<1e-16) compared to participants that           
were recruited as non-disease controls(Median=6 days) (Figure 2-e). Median retention          
time also showed a marked and significant increase of 40 days (P<1e-16) for             
participants that were referred by a clinician to join one of the two studies (mPower and                
ElevateMS)(Median=44 days) compared to participants who self-selected to join the          
same study (Median=4 days) (Figure 2-f). See Supplementary tables 1-6 for a further             
breakdown of survival analysis results. Sensitivity analysis by including participants with           
missing age showed no impact on the association of age with participant retention.             
However, participants with missing demographics showed variation in retention         
compared to participants who shared their demographics(Supplementary Figure 1). This          
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 could be related to different time points at which demographic related questions were             
administered in individual studies. 
 
Participant Daily Engagement Patterns  
In the subgroup of participants who engaged with study apps for a minimum of 7 days,                
overall app usage clustered into four distinct groups with high (the dedicated cluster C1,              
and high utilizers in C2), moderate (cluster C3) and Sporadic (cluster C4) engagement             
(Figure 3.b). The participants who did not participate for at least 7 days were placed in a                 
separate group of participants (the abandoners-C5*)(See Methods for cluster size          
determination and exclusion criteria details). The engagement and demographic         
characteristics across these five groups (C1-5*) varied significantly. Cluster 1 and 2            
showed the highest daily app usage (Median app usage in the first 84 days = 96.4%                
and 63.1 % respectively) but also had the smallest proportion of participants (Median             
=9.5%) with the exception of Brighten where 23.7% of participants belonged to cluster             
C1. While daily app usage declined significantly for both moderate and sporadic clusters             
(C3- 21.4% and C4-22.6%), the median number of days between app usage was             
significantly higher for participants in the sporadic C4 cluster (Median=5 days)           
compared to cluster C3(Median=2 days). The majority of participants (median 54.6%)           
across the apps were linked to the abandoner group(C5*) with the median app usage of               
just 1 day(Figure 4.a-b). Furthermore, distinct demographic characteristics emerged         
across these five groups. Higher engagement clusters (C1-2) showed significant          
differences(P=1.38e-12) in proportion of adults 60 years and above (Median range           
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 =15.1-17.2% across studies) compared to lower engagement clusters C3-5*(Median         
range =5.1-11.7% across studies)[Figure 4-c]. Minority groups such as         
Hispanic/Latinos, Asians, and African-American/Black, on the other hand, were         
represented in higher proportions in the clusters (C3-5*)(P=4.12e-10) with the least           
engagement(Figure 4-d] (See supplementary table 8 for further details).  
 
 
Discussion 
 
Our findings are based on one of the largest and diverse engagement dataset compiled              
to date. We identified two major challenges with remote data collection: (1) more than              
half of the participants discontinued participation within the first week of a study but that               
the rates at which people discontinued was drastically different based on age, disease             
status, clinical referral, and use of monetary incentives and (2) most studies were not              
able to recruit a representative sample, either demographically or regionally. Although           
these findings raise questions about the reliability and validity of data collected in this              
manner, they also shed light on potential solutions to overcome biases in populations             
using a combination of different recruitment and engagement strategies. 
 
One solution could be the use of a flexible randomized withdrawal design​42​. Temporal             
retention analysis (Figure 2-c) shows that a run-in period could be introduced in the              
research design, wherein participants who are not active in the study app in the first               
week or two of the study can be excluded after enrollment but before the start of the                 
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 actual study. The resulting smaller but more engaged cohort will help increase the             
statistical power of the study but does not fix the potential bias​43​.  
 
Another solution is to rely on monetary incentives to enhance engagement. Although            
only one study paid participants, the significant increase in retention and the largest             
proportion of frequent app users indicate the utility of the fair-share compensation            
model​1,44,45 in remote research. Such “pay-for-participation” model could be utilized by           
studies that require long-term and frequent remote participation. Researchers         
conducting case-control studies should also plan to further enrich and engage the            
population without the disease. Studies run the risk of not collecting sufficient data from              
controls to perform case-control analysis with participants without disease seen to be            
dropping out significantly early. Similarly, more efforts​46–48 are needed to retain the            
younger population that, although demonstrating large enrollment also features a          
majority dropping out on day one. 
 
Distinct patterns in daily app usage behavior, also shown previously​49​, further           
strengthen the evidence of unequal technology utilization in remote research. The           
majority of the participants found in the abandoners group (C5*) who dropped out of the               
study on day 1, may also reflect initial patterns in willingness to participate in research,               
in a way that cannot be captured by recruitment in traditional research. Put another way,               
although there is significant dropout in remote trials, these early drop-outs may be able              
to yield very useful information about differences in people who are willing to participate              
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 in research and those who are not willing to participate. For decades clinical research              
has been criticized for its potential bias because people who participate in research may              
be very different from people who do not participate in research​50–52​. Although            
researchers will not have longitudinal data from those who discontinue participation           
early, the information collected during onboarding can be used to assess potential            
biases in the final sample and may inform future targeted retention strategies.  
 
Only 1 in 10 participants were in the high app use clusters (C1-2), and these clusters                
tended to be largely Non-Hispanic whites and older adults. Minority and younger            
populations, on the other hand, were represented more in the clusters with the lowest              
daily app usage (Figure 4-d). The largest impact on participant retention (>10 times) in              
the present sample was associated with clinician referral for participating in a remote             
study. This referral can be very light touch in nature, for example in the ElevateMS               
study, it consisted solely of clinicians handing patients a flyer with information about the              
study during a regular clinic visit. This finding is understandable, given recent research​53             
showing that the majority of Americans trust medical doctors.  
 
With the exception of Brighten study, the recruited sample was also inadequately            
diverse highlighting a persistent digital divide​54 and continued challenges in the           
recruitment of racial and ethnic underserved communities​55​. Additionally, the         
underrepresentation of States in the southern, rural and midwest regions indicates that            
areas of the US that often bear a disproportionate burden of disease​56 are             
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 under-represented in digital research​57​,​56​,​58​. This recruitment bias could impact future          
studies that aim to collect data for health conditions that are more prevalent among              
certain demographic​59 and associated with geographic groups​60​. Using different         
recruitment strategies​46–48 including targeted online ads in regions known to have a            
larger proportion of the minority groups, partnerships with local community          
organizations and clinics may help improve the penetration of remote research and            
improve diversity in the recruited sample. The ongoing “All of Us” research program             
that includes remote digital data collection has shown the feasibility of using a             
multifaceted approach to recruit a diverse sample with a majority of the cohort coming              
from communities underrepresented in biomedical research​61​. Additionally, simple        
techniques such as stratified recruitment that is customized based on the continual            
monitoring of the enrolling cohort demographics, can help enrich for a target population.  
 
Finally, communication in digital health research may benefit from adopting the diffusion            
of innovations approach​62,63 that has been applied successfully in healthcare settings to            
change behavior including the adoption of new technologies​64–66​. Research study          
enrollments, advertisements including in-app communication and return of information         
to participants​67​, could be tailored to fit three distinct personality types (trendsetters,            
majority, and laggards). While trendsetters will adopt innovations early, they are a            
minority (15%) compared to the majority (greater than two-thirds of the population) who             
will adopt a new behavior after hearing about its real-benefits, utility and believe it is the                
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 status quo. On the other hand, laggards (15%) are highly resistant to change and hard               
to reach online and as a result, will require more targeted and local outreach efforts.  
 
These results should also be viewed within the context of limitations related to             
integrating diverse user-engagement data across digital health studies that targeted          
different disease areas with varying underlying disease characteristics and severity. We           
did not take into account differences in recruitment strategies used by the study apps.              
The present retention analysis is based on the “completed” tasks and did not account              
for incomplete tasks or time participants spent in the app. While sensitivity analysis             
showed the main findings from user retention analysis do not change by including             
participants with missing data, however, missing demographic characteristics remains         
to be a significant challenge for digital health(See supplementary table 7). Researchers            
should prioritize to collect minimal demographic data such as age, gender,           
race/ethnicity, participant state during onboarding which help characterize user attrition          
in future studies.  
 
Despite these limitations, the present investigation to the best of our knowledge is the              
largest cross-study analysis of participant retention in remote digital health studies.           
While the technology has enabled researchers to reach and recruit participants for            
conducting large scale health research in short periods of time, more needs to be done               
to ensure equitable access and long-term utilization by participants across different           
populations. The low retention in “fully remote, app-based” health research may also            
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 need to be seen in the broad context of the mobile app industry where similar user                
attrition is reported​68​. Attrition in remote research may also be impacted by study             
burden​30 as frequent remote assessments can compete with users' everyday priorities           
and perceived value proposition for completing a study task that may not be linked to an                
immediate monetary incentive. Using co-design techniques​69 for developing study apps          
involving researchers and participants could help guide the development of most           
parsimonious research protocols that fit into the daily lives of people and are still              
sufficiently comprehensive for researchers.  
 
In the present diverse sample of user-activity data, several cohort characteristics such            
as age, disease status, clinical referral, monetary benefits, etc have emerged as key             
drivers for higher retention. These characteristics may also guide the development of            
new data-driven engagement strategies​70,71 such as tailored just-in-time interventions​72         
targeting sub-populations that are most likely to drop out early from remote research.             
Left unchecked the ongoing bias in participant recruitment combined with inequitable           
long-term participation in large scale “digital cohorts” can severely impact the           
generalizability​36,37 and undermine the promise of digital health in collecting          
representational real-world data.  
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 Online Methods 
 
 
Data Acquisition 
 
The user engagement data was collected from eight digital health studies assessing            
different diseases ranging from parkinson's, asthma, heart condition, sleep health,          
multiple sclerosis to depression(Table 1). These studies recruited participants from          
throughout the US between 2014-2019 using a combination of different approaches           
including placing ads on social media, publicizing or launching the study at a large              
gathering, partnerships with patient advocacy groups, clinics, and through word of           
mouth. The studies were launched at different time points during the 2014-2019 period,             
including three studies mPower, MyHeartCounts, and Asthma being launched with the           
public release of ResearchKit framework​73 released by Apple in March 2015. The            
studies were also active for different time periods including significant differences in the             
minimum time participants were expected to participate in the studies remotely. While            
Brighten and ElevateMS had a fixed 12 week participation period, other studies allowed             
participants to remain active for as long as they desired. Given this variation in the               
expected participation period across the studies, we selected the minimum common           
time period of the first 12 weeks(84 days) of each participant’s activity in each study for                
retention analysis. Finally, with the exception of Brighten study which was a            
randomized interventional clinical trial and enrolled depressed cohort offering them          
monetary incentives for participation, the rest of the seven studies were observational            
and did not offer any direct incentives for participation and were open to people with and                
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 without target disease. The studies also collected different real-world data ranging from            
frequent subjective assessments, objective sensor-based tasks to continual passive         
data​41​ collection. 
 
Data Harmonization 
User activity data across all the apps were harmonized to allow for inter-app             
comparison of user engagement metrics. All in-app surveys and sensor-based tasks           
(eg. Finger tapping on the screen) were classified as “active tasks” data type. The data               
gathered without explicit user action such as daily step count (Apple’s health kit API),              
daily local weather patterns were classified as “passive” data type and was not used for               
assessing active user engagement. The frequency at which the active tasks were            
administered in the study apps were aligned based on the information available in the              
corresponding study publication or obtained directly from the data contributing team in            
case the data was not publicly available. Furthermore, there were significant differences            
in the baseline demographics that were collected by each app. A minimal subset of four               
demographic characteristics (age, gender, race, state) was used for participant          
recruitment and retention analysis. A subset of six studies(mPower, ElevateMS,          
SleepHealth, Asthma, MyHeartCounts) had enrolled participants with and without         
disease status and were used to asses retention differences between people with(case)            
and without(control) disease. Two studies(mPower and ElevateMS) had a subset of           
participants that were referred to use the same study app by their care providers. For               
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 this smaller but unique sub-group, we compared the retention differences between           
clinically referred participants to self-referred participants. 
 
Statistical Analysis 
We used three key metrics to assess participant retention and long-term engagement.            
1) Duration in the study: the total duration, a study participant remained active in the               
study i.e the number of days between the first and last active task completed by the                
participant, during the first 84 days of each participant’s time in the study. 2) Days active                
in the study: the number of days a participant performed any active task in the app. 3)                 
User activity streak: a binary-encoded vector representing the 84 days of app            
participation for each participant(Figure 3-a) where the position of the vector indicates            
the participant’s day in the study and is set to 1(green box, Figure 3-a) if at least one                  
active task is performed on that day or else is 0(white). User activity streak was used to                 
assess sub-populations that show similar longitudinal engagement patterns over a 3           
month period.  
 
Participant retention analysis(survival analysis​74​) was done using the total duration in           
the study metric to compare the retention differences across studies, sex, age group,             
disease status, and clinical referral for study-app usage. Log-rank test​75 stratified by            
study type was used to compare significant differences in participant retention between            
different comparator groups. Kaplan-Meier​76 plots were used to summarize the effect of            
the main variable of interest by pooling the data across studies where applicable. Two              
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 approaches were used to evaluate participant retention using survival analysis. 1) No            
censoring(most conservative) - If the last active task completed by participant fell within             
the pre-specified study period of first 84 days, we considered it to be a true event i.e                 
participant leaving the study (considered “dead” for survival analysis). b)          
Right-censoring​76 - To assess the sensitivity of our findings using approach 1, we             
relaxed the determination of true event (participant leaving the study) in the first 12              
weeks to be based on the first 20 weeks of app activity (additional 8 weeks). For                
example, if a participant completes last task in an app on day 40(within the first 84 days)                 
and then additionally completes more active task/s between week 13-20 he/she was still             
considered alive (no event) during the first 84 days(12 weeks) of the study and therefore               
“right-censored” for survival analysis. 
 
Given that age and gender had a varying degree of missingness across studies;             
additional analysis comparing the retention differences between the two sub-groups that           
provided the demographics and that opted out was done to assess the sensitivity of              
missing data on main findings. Unsupervised k-means clustering was used to           
investigate the longitudinal participant engagement behavior within each study. The          
number of optimum clusters(between 1-10) in each study was determined using the            
elbow method​77 that aims to minimize the within-cluster variation. Enrichment of           
demographic characteristics in each cluster was assessed using a one-way analysis of            
variance(ANOVA). Since the goal of this unsupervised clustering of user activity streaks            
was to investigate the patterns in longitudinal participant engagement; we filtered out            
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 individuals who remained in the study for less than 7 days from clustering analysis.              
However, for post hoc comparisons of demographics across the clusters, the initially            
left-out users were put in a separate group (C5*). The state-wise proportions of             
recruited participants in each app were compared to the 2018 US state population             
estimates using the data obtained from the US census bureau​78​. To eliminate potential             
bias related to marketing and advertising of the launch of Apple’s Research kit platform              
on March 09, 2015, participants who joined and left the mPower, MyHeartCounts,            
Asthma studies within the first week of Research Kit launch (N=15,413) were taken out              
from the user retention analysis. We initially considered using cox proportional hazards            
model​79 to test for the significance of variable of interest on user retention within each               
study accounting for other study-specific covariates. However, because the assumption          
of proportional hazards (tested using scaled Schoenfeld residuals) was not supported           
for some studies, these analyses were not further pursued. All statistical analyses were             
performed using R​80​. 
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 Figure & Tables 
 
 
 
 
Figure 1. ​a) Map of US showing the ratio of the percentage of recruited participants to state’s                 
population proportion of the US(median across the studies) and ​b) ​Race/Ethnicity proportion(median            
+/- IQR) of recruited participants compared to 2010 census data.  
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Figure 2: ​a) ​Proportion of active tasks (N = 3.3 million) completed by participants based on their local                  
time of day, b) Kaplan Meir survival curve showing significant differences(P < 1e-16) in user retention                 
across the apps. Brighten App where monetary incentives were given to participants showed the              
longest retention time(Median ​= 26 days, 95% CI= 17-33) followed by Asthma(Median ​= 12 days, 95%                
CI= 11-13), MyHeartCounts(Median ​= 9 days, 95% CI= 9-9), ElevateMS(Median ​= 7 days, 95% CI=               
5-10), mPower(Median ​= 5 days, 95% CI= 4-5), Phendo(Median ​= 4 days, 95% CI= 3-4), Start(Median ​=                 
2 days, 95% CI= 2-2) and SleepHealth(Median ​= 2 days, 95% CI= 2-2), ​c) ​Lift curve showing the                  
change in median survival time (with 95% CI) based on the minimum number of days(1-32) a subset of                  
participants continued to use the study apps, Kaplan-Meier survival curve showing significant            
differences in user retention across ​d) Age group, with 60 years and older using the apps for longest                  
duration(Median=7days, 95%CI=6-8, P < 1e-16) followed by 50-59 years (Median ​=4 days, 95%CI=             
4-5) and 17-49 years (Median ​= 2-3 days, 95% CI= 2-3) ​e) ​Disease status; participants reporting having                 
a disease stayed active longer(N​50​= 13days, 95% CI=13-14) compared to people without disease(N​50​=             
6 days, 95% CI=5-6) and finally ​f) ​Clinical referral; Two studies (mPower and ElevateMS), had a                
subpopulation, that were referred to the study by clinicians and showed significantly(P<1e-16) longer             
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 app usage period(Median= 44 days, 95% CI=27-58) compared to self-referred participants with disease             
(N​50​= 4 days, 95% CI=4-4).  
 
 
Figure 3: ​a) Schematic representation of an individual’s in-app activity for the first 84 days. The                
participant app usage time is determined based on the number of days between the first and last day                  
they perform an active task(indicated by the green box) in the app. Days active in the study is the total                    
number of days a participant performs at least one active task (indicated by the number of green boxes).                  
b) Heatmaps showing participants in-app activity across the apps for the first 12 weeks(84 days),               
grouped into four broad clusters using unsupervised k-means clustering. The optimum number of             
clusters was determined by minimizing the within-cluster variation across different cluster sizes between             
1-10. Seven out of eight studies indicated four clusters to be an optimum number using the elbow                 
method. The heatmaps are arranged by the highest (C1) to the lowest user engagement cluster (C4).  
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Figure 4: a) ​Proportion of participants in each cluster across the study apps, ​b) Participants total                 
app usage duration(between 1-84 days) and the number of days participants completed tasks in              
the study apps, ​c) Significant differences[F(4,163)=18.5, P=1.38e-12] in proportion of participants           
aged 17-29 years and 60 years and older across the 5 clusters and ​d) ​Significant               
differences[F(2,81)=28.5, P=4.12e-10] in proportion of minority population present in the five           
clusters. C5* cluster contains the participants that used the apps for less than a week and were                 
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 removed from the clustering, however, they were added back for accurate proportional comparison             
of participants in each cluster. 
Study Disease Focus / Study type Study period 
Number of 
participants 
Total 
participant 
days 
Active tasks 
completed 
Start 
Antidepressant Efficacy - 
Observational Aug,2015 - Feb,2018 42,704 280,489 1,219,656 
MyHeartCounts 
Cardiovascular Health - 
Observational Mar,2015 - Oct,2015 26,902 165,455 305,821 
SleepHealth 
Sleep Apnea -  
Observational Jul,2015 - Jun,2019 12,914 99,696 401,628 
mPower 
Parkinson's -  
Observational Mar,2015 - Jun,2019 12,236 104,797 568,685 
Phendo 
Endometriosis -  
Observational Dec,2016 - Jul,2019 7,802 81,938 735,778 
Asthma 
Asthma -  
Observational Mar,2015 - Dec,2016 5,875 77,815 175,699 
Brighten 
Depression -  
Randomized Control Trial Jul,2014 - Aug,2015 876 34,987 45,951 
ElevateMS 
Multiple Sclerosis -  
Observational Aug,2017 - Jul,2019 605 11,211 31,568 
   109,914 856,388 3,484,786 
 
Table 1: Summary of  user engagement data compiled from eight digital health 
studies 
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Asthma Brighten ElevateMS mPower MyHeart
Counts 
Phendo SleepHealth Start Overall 
(median) 
Age group          
N 2512 875 569 6810 1555 7484 12392 42690  
18-29(%) 43.31 50.06 10.9 31.5 25.08 55.38 32.79 55.72 38 
30-39(%) 27.83 25.14 26.54 18.37 32.67 36.09 28.72 24.14 27.2 
40-49(%) 14.41 14.74 28.47 13.19 16.27 8.23 20.77 12.38 14.6 
50-59(%) 9.08 6.97 22.14 13.61 12.09 0.25 11 5.26 10 
60+(%) 5.37 3.09 11.95 23.33 13.89 0.04 6.72 2.51 6 
Sex          
N 2509 875 329 6916 6976 7532 12558 42704  
Female(%) 39.58 77.83 74.16 28.93 18.94 100 29.14 75.86 56.9 
Race          
N 3274 875 334 6884 4703 7530 5311 -  
Non-Hispanic White(%) 68.69 60.11 80.84 75.32 77.95 81.29 74.13 - 75.3 
Hispanic/Latinos(%) 13.29 14.29 4.79 8.21 6.97 5.67 12.82 - 8.21 
African-American/Black(%) 4.95 10.86 6.89 2.05 3.1 2.71 3.45 - 3.45 
Asian(%) 4.98 8.23 2.99 8.4 7.72 2.79 5.87 - 5.9 
Hawaiian or other Pacific 
Islander(%) 
0.89 0.57 0 0.28 0.32 0 0.23 - 0.3 
AIAN(%) 0.43 0.46 0 0.65 0.53 0.74 0.28 - 0.5 
Other(%) 6.78 5.49 4.49 5.1 3.4 6.8 3.22 - 5.1 
Duration in Study 
(Median +/- IQR) 12 ± 38 26 ± 82 7 ± 45 4 ± 21 9 ± 19 4 ± 25 2 ± 8 2 ± 16 5.5 
Days active tasks 
performed 
(Median +/- IQR) 4 ± 12 14 ± 58 2 ± 8 2 ± 4 4 ± 7 2 ± 6 2 ± 4 2 ± 4 2 
 
Table 2: Summary of select participant demographics and study app usage 
across the eight digital health studies 
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